No abstract available
Keywords:
CANCER; LUNG CANCER; ONCOLOGY.
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Biomarkers, Tumor / genetics*
-
Biopsy
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / enzymology
-
Carcinoma, Non-Small-Cell Lung / genetics
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Carcinoma, Squamous Cell / enzymology
-
Carcinoma, Squamous Cell / genetics
-
Carcinoma, Squamous Cell / pathology*
-
DNA Mutational Analysis
-
Disease Progression
-
Drug Resistance, Neoplasm
-
ErbB Receptors / antagonists & inhibitors*
-
ErbB Receptors / genetics*
-
ErbB Receptors / metabolism
-
Erlotinib Hydrochloride
-
Fatal Outcome
-
Female
-
Genetic Predisposition to Disease
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / enzymology
-
Lung Neoplasms / genetics
-
Lung Neoplasms / pathology
-
Middle Aged
-
Molecular Targeted Therapy
-
Mutation*
-
Phenotype
-
Protein Kinase Inhibitors / therapeutic use*
-
Quinazolines / therapeutic use*
-
Time Factors
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
Protein Kinase Inhibitors
-
Quinazolines
-
Erlotinib Hydrochloride
-
EGFR protein, human
-
ErbB Receptors